Search Within

Martin Henner Voss

  1. "2014"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (3)
Groups
  1. Department of Medicine (17)
  2. Genitourinary Oncology Service (17)
  3. Solid Tumor Oncology Division (17)
  4. Epidemiology and Biostatistics (4)
  5. Human Oncology and Pathogenesis Program (4)
  6. Surgery (4)

More Groups

People
  1. Robert Motzer (8)
  2. James Hsieh (6)
  3. Abraham Hakimi (3)
  4. Paul Russo (3)
  5. Victor Reuter (3)
  6. Ana Maria Molina (2)

More People

Years
  1. 2014 (17)
Publications
  1. Journal of Clinical Oncology (9)
  2. BJU International (4)
  3. Annals of Oncology (2)
  4. American Journal of Surgical Pathology (1)
  5. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (9)
  2. Wiley Blackwell (4)
  3. Oxford University Press (2)
  4. American Association for Cancer Research (1)
  5. Lippincott Williams & Wilkins (1)

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Amin, A.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B.; McDermott, D. F.; Knox, J.; Pal, S. K.; Voss, M. H.; Sharma, P.; more...
    BJU International (2014)

    Fulltext@MSK | Save
  • Src pathway activation in RCC and the correlation with grade and survival and the development of a rational new target in RCC
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Mano, R.; Motzer, R. J.; Hsieh, J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Integrated analysis of metastatic disease in clear cell renal cell carcinoma: A collaborative TCGA analysis
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mano, R.; Gonen, M.; Voss, M. H.; Reuter, V. E.; Rathmell, K.; Maranchie, J. K.; Appleman, L. J.; Tamboli, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and efficacy of targeted therapy for renal cell carcinoma (RCC) with brain metastasis
    Meeting Abstract

    Bastos, D. A.; Molina, A. M.; Jia, X. Y.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: Recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry
    Journal Article

    Chen, Y. B.; Brannon, A. R.; Toubaji, A.; Dudas, M. E.; Won, H. H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Voss, M. H.; more...
    American Journal of Surgical Pathology (2014)

    Fulltext@MSK | Save
  • Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies
    Journal Article

    Voss, M. H.; Bastos, D. A.; Karlo, C. A.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Hsieh, J. J.; Molina, A. M.; Patil, S.; Motzer, R. J.
    Annals of Oncology (2014)

    Fulltext@MSK | Save